MyFinsight
Home
Blog
About
Back
Income Statement
TScan Therapeutics, Inc. (TCRX)
TScan Therapeutics, Inc. (TCRX)
source: myfinsight.com
Comprehensive loss
-$30,359K
Interest and other
income, net
$833K
(-65.15%↓ Y/Y)
Net loss
-$30,359K
(17.84%↑ Y/Y)
Total other income
$134K
(-92.12%↓ Y/Y)
Interest expense
$699K
(1.45%↑ Y/Y)
Loss from operations
-$30,493K
(21.11%↑ Y/Y)
Collaboration and license
revenue
$1,051K
(-65.83%↓ Y/Y)
Total operating
expenses
$31,544K
(-24.41%↓ Y/Y)
Research and development
$23,402K
(-28.29%↓ Y/Y)
General and
administrative
$8,142K
(-10.48%↓ Y/Y)
Back